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1. Introduction
  Cancer is one of the leading causes of human death. In 
modern medicine, chemotherapy, radiotherapy and surgery 
are the major treatments available for cancer. Intervention 
with chemo preventive agents in the early stage of 
carcinogenesis is theoretically more rational than attempting 
to eradicate fully developed tumors with chemotherapeutic 
agents. These agents have a narrow margin of safety and the 
therapy may fail due to drug resistance and dose-limiting 
toxicities, which may severely affect the host cells. Hence 
the use of natural products is an alternative in the control 
and eradication of cancer. Medicinal plants are playing an 
important role as a source of effective anticancer agents and 
it is significant that 60% of currently used anticancer agents 
are derived from natural sources including plants[1]. There 
is a growing interest in the pharmacological evaluation 
of various plants used in Indian traditional system of 
medicine.
  Indigofera cassioides Rottl. Ex. DC. (Syn: Indigofera 
pulchella Roxb.) (I. cassioides) belonging to the family 
Fabaceae, is a large shrub, distributed throughout the 
hills of India. The flowers of the plant are reported to be 
antiscorbutic, diuretic and alternative. A decoction of the 
root is given for cough and its powder is applied externally 
for chest pain. The leaves and roots are used for swelling of 
the stomach [2, 3]. The leaves are used by tribes and native 
medical practitioners to treat diseases such as arthritis, 
inflammation, tumor and liver diseases. However, there 
is no phytochemical and pharmacological evaluation has 
been carried out on I. cassioides. Based on this evidence we 
have selected I. cassioides for the present study. The aim of 
the present study is to evaluate the antitumor properties of 
the methanol extract of I. cassioides (MEIC) against Ehrlich 
ascites carcinoma (EAC) and Dalton’s lymphoma ascites 
(DLA) tumor models along with its antioxidant status.
 
2. Materials and methods
Objective: To evaluate the antitumor, cytotoxic and antioxidant activities of methanolic leaf 
extract of Indigofera cassioides (MEIC) against transplantable tumors and human cancer cell 
lines. Methods: MEIC was investigated for its short term cytotoxicity on EAC and DLA cells by 
trypan blue dye exclusion method and in vitro cytotoxicity on HeLa, HEp-2, HEpG-2, MCF-7, 
HT-29, Vero and NIH 3T3 cells by MTT assay. In vivo antitumor activity was studied on EAC and 
DLA tumor bearing mice. Activity was assessed by monitoring the mean survival time, effect on 
hematological parameters, antioxidant enzyme levels and solid tumor volume. Results: MEIC 
exhibit potent in vitro cytotoxicity against all the tested cancer cell lines, but it was found to be 
safe on normal cells. The extract significantly (P<0.001) increase the mean survival time and also 
have a protective effect on the hemopoietic system at the tested dose levels (200 and 400 mg/kg). 
The extract prevented lipid peroxidation and restored the antioxidant enzymes catalase, 
superoxide dismutase, glutathione peroxidase and glutathione-s-transferase in the liver of tumor 
control animals. It also significantly (P<0.01) reduce the solid tumor volume. Conclusions: The 
results strongly support that MEIC shows potent antitumor and cytotoxic effects against EAC, DLA 
and human cancer cell lines. The extract prevents lipid peroxidation and promotes the enzymatic 
antioxidant defense system in tumor bearing animals which might be due to activities like 
scavenging of free radicals by the phytochemicals in MEIC.
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2.1. Chemicals
  5-Fluorouracil (5-FU) was obtained from Dabur 
Pharmaceutical  Ltd (New Delhi ,  India) .  Trypan 
blue ,  th iobarbi tur ic  ac id ,  t r ichloroacet ic  ac id , 
ethylenediaminetetracetic acid (EDTA), RPMI-1640 media 
and 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltertazolium 
bromide (MTT) were procured from HiMedia (Mumbai, 
India). Dimethyl sulfoxide and methanol were obtained from 
Loba Chemie (Mumbai, India). All other chemicals used 
were of analytical grade.
2.2. Plant material and extraction
  Leaves of I. cassioides were collected from the Yercaud 
hills in the month of November 2008. The plant was 
authenticated by Dr. G.V.S. Murthy, Joint Director, 
Botanical Survey of India, Coimbatore, Tamilnadu, India.  A 
voucher specimen is preserved in our laboratory for future 
reference (Voucher No. P. Ch. IC 003/2008). The plant 
material was shade dried, pulverized and extracted (500 g) 
with 80% methanol at room temperature for 72 h. The extract 
was filtered and concentrated to dryness under reduced 
pressure and controlled temperature (40-50 曟) in a rotary 
evaporator. The extract was a dark brown solid weighing 41 g
(yield, 8.2 %) and was preserved in a vacuum desiccator at
4 曟 until further use.
2.3. Preliminary phytochemical analysis
  The extract was analyzed for the presence of various 
phytochemical constituents employing standard screening 
tests [4]. Conventional protocol for detecting the presence of 
steroids, alkaloids, tannins, flavonoids, glycosides, etc., was 
used.
2.4. Tumor cells and inoculation
  Normal mouse embryonic fibroblast (NIH 3T3), normal 
African green monkey kidney Cells (Vero), human cervical 
cancer cells (HeLA), human laryngeal epithelial carcinoma 
(HEp-2), human liver cancer cells (HEpG-2), human breast 
cancer cells (MCF-7) and human colon cancer cells (HT-
29) were obtained from National Centre of Cell Sciences 
(Pune, India). The cultures were maintained in Dulbecco’s 
modified eagles medium (DMEM) containing 10 % inactivated 
calf serum and were grown in 25 cm2 tissue culture flasks 
(Tarson Products Ltd, Kolkatta, India) until confluence and 
use for cytotoxic assays. EAC and DLA cells were supplied 
by Amala Cancer Research Centre (Trissur, Kerala, India). 
The cells were maintained in vivo in Swiss albino mice by 
intraperitoneal transplantation. Tumor cells aspirated from 
the peritoneal cavity of mice were washed with normal 
saline and used for further studies.
2.5. Short term cytotoxic activity
  Short term cytotoxicity was assessed by incubating 1 伊106
EAC or DLA cells in 1 mL phosphate buffered saline at 
varying concentrations (31.25 - 1000 毺g/mL) of the MEIC 
at 37 曟 for 3 h under a CO2 atmosphere. The viability of the 
cells was determined by trypan blue dye exclusion method 
[5].
2.6. In vitro cytotoxicity on human cancer cell lines 
  Stock cells of normal mouse embryonic fibroblast (NIH 3T3), 
normal African green monkey kidney cells (Vero), human 
cervical cancer cells (HeLA), human laryngeal epithelial 
carcinoma (HEp-2), human liver cancer cells (HEpG-2), 
human breast cancer cells (MCF-7) and human colon 
cancer cells (HT-29) were cultured in RPMI-1640 and DMEM 
supplemented with 10 % calf serum, penicillin (100 IU/mL)
and streptomycin (100 μg/mL) in a humidified atmosphere 
of 5 % CO2 at 37 曟 until confluent. The cells were 
dissociated with 0.2 % trypsin and 0.02% EDTA in PBS. The 
cytotoxic assay was carried out by adding 0.1 mL of cell 
suspension containing 10 000 cells to each well of a 96-well 
microtitre plate (Tarson, Kolkatta, India) and fresh medium 
containing various concentrations of extract was added at 
24th h after seeding. Control cells were incubated without 
the extract and with DMSO. The microtitre plates were 
incubated at 37 曟 in a humidified atmosphere with 5 % CO2 for a 
period of 72 h. The percentage cytotoxicity was determined 
by the standard MTT assay method and IC50 was calculated [6].
2.7. Animals
  Healthy male swiss albino mice weighing (25依2) g were 
obtained from Venkateshwara Enterprises, Banglaore, India. 
The mice were grouped and housed in polypropylene cages 
and maintained under standard conditions (25依2) 曟 with 
12 h dark/light cycle. The animals were fed with standard 
animal pellet diet and water ad libitum. The experiment 
protocols received clearance from the Institutional Animal 
Ethical Committee (IAEC) and CPCSEA, Chennai, India 
(Proposal No: SVCP/IAEC/Ph.D/01/2008-09 dt 24.12.2008).
2.8. Acute toxicity studies
  The oral acute toxicity study of MEIC was carried out in 
Swiss albino mice using the OECD guidelines 423 [7]. The 
animals received MEIC starting at 2 g/kg orally by gavage. 
The animals were observed for toxic symptoms and mortality 
continuously for first 4 h after administration. Finally, 
the number of survivors was noted after 24 h and these 
animals were then maintained for further 13 days with daily 
observations.
2.9. Antitumor studies
  Antitumor activity of MEIC was evaluated by the procedure 
described by Senthil Kumar et al., [8]
2.9.1. Effect of MEIC on survival time
  Healthy Swiss albino mice were divided into eight groups 
(I-VIII) each group consisting of six animals. Group I - IV 
were inoculated with EAC cells (1 x 106 cells/mouse) and 
Group V-VIII were inoculated with DLA cells (1伊106 cells/
mouse) on day ‘0’ and treatment with MEIC started 24 h 
after inoculation. Group I and V served as tumor control 
which received the vehicle (CMC, 0.3 %). Group II and VI 
were treated with the standard drug (5-FU, 20 mg/kg) by 
intraperitoneal route. Group III, IV, VII and VIII received 
the plant extract at the dose of 200 mg/kg and 400 mg/kg 
by oral route, respectively. All the treatments were given 
for nine days. The median survival time and percentage 
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increase in life span was calculated. 
% increase in life span = [T-C/C]伊 100
Where, T= No. of days the treated animals survived
 C= No. of days the control animals survived
2.9.2. Effect of MEIC on hematological parameters
  In order to detect the influence of MEIC on hematological 
status of tumor bearing animals, a comparison was made 
among eight groups (n=5 animals per group) of mice on 
the 14th day after inoculation. Group I and V served as 
normal control which received the vehicle (CMC, 0.3 %). 
Group II and VI served as tumor control for respective cell 
lines. Group III, IV, VII and VIII were treated with the 
plant extract at the dose of 200 mg/kg and 400 mg/kg by 
oral route for nine days. Blood was drawn from each mouse 
by retro orbital plexus method after anaesthetized slightly 
with anesthetic ether. The hematological parameters like 
hemoglobin (Hb), red blood cells (RBC), white blood cells 
(WBC), platelets (PLT), lymphocytes (LYM), hematocrit 
(HCT), hemoglobin (HGB), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin concentration (MCHC), 
red blood cell distribution width (RDW) and MID cells 
(less frequently occurring and rare cells correlating to 
monocytes, eosinophils, basophils etc.,) were determined 
by using a blood automatic analyzer (Celldyn, Abbot Inc. 
USA). After blood collection, animals were sacrificed 
by cervical dislocation. The liver from each mouse was 
excised and rinsed in ice cold normal saline solution. A 
10 %w/v liver homogenate was prepared in ice cold 10 % 
KCl solution and was centrifuged for 15 min at   4 曟. The 
supernatant, thus was obtained and used for the estimation 
of lipid peroxidation (LPO) [9], catalase (CAT) [10], superoxide 
dismutase (SOD) [11], glutathione peroxidase (GPx) [12] and 
glutathione S-transferase (GST) [13]. Ascitic fluid of all group 
animals, except normal, were smeared and stained with 
Lieshman stain solution for cytological studies.
2.9.3. Effect of MEIC on solid tumor volume
  Mice were divided into six groups with each group 
consisting of six animals. Group I - III were injected with 
EAC cells (2 伊 106 cells/mouse) into the right hind limb of 
the animals intramuscularly. In the same way, the animals 
from Group IV - VI were injected with DLA cells (2 伊 106 
cells/mouse) into the right hind limb, intramuscularly. 
Group I and IV served as tumor control. Group II, III, V and 
VI were treated with MEIC at the dose of 200 mg/kg and 400 
mg/kg by oral route, respectively, for five alternative days. 
From the 15th day onwards, tumor diameter was measured 
every fifth day and recorded up to 30 days by using vernier 
calipers. The tumor volume was calculated by using the 
formula V = 4/3 πr2, where ‘r’ is the mean of r1 and r2 
which are the two independent radii of the tumor mass.
2.10. Statistical analysis  
  All the values were expressed as mean 依 SEM. The data 
were statistically analyzed by one-way ANOVA, followed 
by Tukey multiple comparison test and data for solid tumor 
volume were analyzed by Dunnett test. P values <0.05 were 
considered as significant. 
3. Results
3.1. Preliminary phytochemical analysis
  The preliminary phytochemical screening revealed that the 
extract contains terpenoids, alkaloids, saponins, glycosides, 
flavonoids and phenolic compounds. 
3.2. Short term cytotoxicity assay
  The IC50 of MEIC was found to be 47.10 μg/mL for EAC cells 
and 72.63 μg/mL for DLA cells.
3.3. In vitro cytotoxic activity
  In the in vitro cytotoxicity studies, the cells were treated 
with various concentrations of the extract (31.25-500 毺g/mL).
The percentage cytotoxicity progressively increased in a 
concentration dependent manner. The IC50 of MEIC was 
found to be below 100 毺g/mL on all the tested human 
cancer cell lines, but it was found to be very high for the 
normal cells. This indicated that MEIC possess selective 
cytotoxicity against the cancer cells, but is safer towards the 
normal cells (Table 1).
3.4. Acute toxicity studies
  In acute toxicity studies, animals treated with MEIC did 
not show any toxic symptoms or mortality when dosed up to 
2 000 mg/kg body weight by oral route. This indicated that 
the extract was found to be safe at the tested dose level. 
Hence 1/10th (200 mg/kg) and 1/5th (400 mg/kg) of this dose 
were selected for the in vivo studies. 
Table 1 
In vitro cytotoxicity studies of methanol extract of I. cassioides against 
human cancer cell lines by MTT assay method.
Cell lines studied IC50 (毺g/mL)*
NIH 3T3 (Normal mouse embryonic fibroblast) 292.40
Vero (Normal African green monkey kidney cells) 280.30
HeLa (Human cervical cancer ) 55.67
HEp-2 (Human laryngeal epithelial carcinoma) 68.45
HEpG2 (Human liver cancer) 46.88
MCF-7 (Human breast cancer) 87.50
HT-29 (Human colon cancer) 50.84
*Average of three determinations, three replicates; IC50: Drug 
concentration inhibiting 50% cellular growth following 72 h of drug 
exposure.
3.5. Effect on mean survival time
  In both EAC and DLA tumor bearing the animals, the 
extract significantly (P<0.001) increased the mean survival 
time and percentage increase in life span in dose dependent 
manner. The results were almost comparable to that of 5-FU, 
the standard drug (Table 2).
3.6. Effect on hematological parameters
  Hematological parameters of both EAC and DLA tumor 
bearing mice on day 14 were found to be significantly 
altered from normal group. There was a significant decrease 
in hemoglobin, RBC and lymphocytes in tumor bearing 
animals, accompanied by an increase in WBC, hematocrit 
(HCT), MID cells and protein. At the same treatment interval, 
MEIC at the dose of 200 and 400 mg/kg changed these altered 
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parameters significantly closer to normal levels. All these 
results suggest the anticancer nature of the extract (Table 
3). The EAC and DLA tumor cells from the ascitic fluid of 
different treatment groups were stained with Lieshman stain. 
They showed marked cytological changes and cytolytic 
activity when compared to the respective tumor control cells 
(Figure 1-6).
Figure 1. Smear showing matured EAC tumor cells with clear cell 
wall without degeneration. 
Figure 2. EAC tumor cells treated with MEIC 200 mg, showing 
degenerative changes in the form of membrane blebbing.
Figure 3. EAC tumor cells treated with MEIC 400 mg, showing 
degenerative changes like membrane blebbing, vacuolated cytoplasm 
and a reduction in the staining intensity.
Figure 4. Smear showing DLA tumor control cells with clear cell wall 
and definite structure of tumor cells.
Figure 5. DLA tumor cells of MEIC 200 mg treated mice, showing 
cell wall destruction and degradation of tumor cells.
Figure 6. DLA tumor cells of MEIC 400 mg treated mice showing 
complete destruction of cell wall, degenerative changes like 
vacuolated cytoplasm, membrane blebbing and low staining intensity.
3.7. Effect on antioxidant parameters
  The levels of lipid peroxidation in liver tissue were 
significantly increased in EAC and DLA tumor control 
groups as compared to the normal group (P<0.001). After 
administration of MEIC at different doses to tumor bearing 
mice, the levels of lipid peroxidation were significantly 
(P<0.001) reduced as compared to tumor control groups. 
Inoculation with the tumor cells drastically increased 
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the GST and GPx content in both tumor control groups 
as compared with normal group. Administration of MEIC 
restored the levels of GST and GPx when compared to tumor 
control group. Decreased levels of superoxide dismutase 
(SOD) and catalase (CAT) in the livers of the EAC and DLA 
tumor bearing mice was observed (P<0.001) when compared 
with normal group. After treatment with MEIC at the tested 
doses, the levels of SOD and catalase were bringing back to 
near normal (Table 4).
3.8. Effect on solid tumor volume
  The solid tumor volumes of EAC & DLA tumor bearing mice 
was presented in Table 5. In EAC tumor bearing animals, the 
lower dose group animals does not show significant activity, 
but higher dose level significantly (P<0.01) reduces the 
tumor volume when compared to tumor control groups. In 
DLA tumor bearing animals, the extract significantly reduce 
the solid tumor volume in dose dependent manner.
Table 2
Effect of methanol extract of I. cassioides on survival & increase in life span of EAC & DLA tumor bearing mice (n=6).
Design of treatment
EAC DLA
     MST   Increase in life span (%)      MST Increase in life span (%)
Tumor control 23.83依1.14 0.00 20.50依0.76 0.00
5-FU 45.50依1.18 a 90.93 40.83依0.60 a 99.17
MEIC 200 37.17依0.70 a,b 55.97 27.17依0.70 a,b 32.53
MEIC 400 42.50依0.76 a 78.35 33.70依1.02 a,b 64.39
MST: Mean survival time. Data were expressed as Mean依SEM, a P<0.001 vs. tumor control; b P<0.001 vs. 5-FU. Data were analyzed by using 
one way ANOVA followed by Tukey Kramer Multiple comparison test.
 
Table 3 
Effect of methanol extract of I. cassioides on hematological parameters of EAC/DLA tumor bearing mice (n=5).
Parameters EAC DLA
Normal Tumor control MEIC 200 MEIC 400 Normal Tumor control MEIC 200 MEIC 400
HGB (g/dL)   15.22依0.33     6.84依0.26a     9.12依0.26a,d 10.88依0.35a,d 12.56依0.58 6.46依0.33a 8.26依0.37a,e 10.98依0.29d
RBC (M/uL)     5.79依0.36     3.32依0.18a     3.69依0.09a 5.21依0.36e 7.16依0.22 4.04依0.09a 4.54依0.21a 5.88依0.32c,d
HCT (%)   17.92依0.69   29.92依1.51a   28.08依1.00a 23.52依0.49b,d 17.66依0.57 30.16依1.76a 21.06依0.62d 18.78依1.09d
MCV (fL)   47.44依0.63   37.66依1.96a   41.16依1.44c 41.40依1.75 47.06依0.82 41.80依1.47c 45.50依0.40 45.40依0.72
MCH (pg)   16.48依0.39   18.18依1.23   16.70依0.29 15.96依0.37 16.72依0.38 16.68依0.88 17.36依0.74 17.24依0.19
MCHC (g/dL)   34.92依0.26   36.06依0.82   35.10依0.75 34.64依0.39 34.88依0.46 37.28依1.11 34.52依0.37 36.40依0.77
RDW (%)   24.96依0.69   17.46依0.50a   17.98依0.46a 23.28依1.10d 17.36依0.70 18.58依0.44 18.14依0.51 17.94依0.85
PLT (K/uL) 635.00依25.42 755.20依13.67b 713.00依15.29 613.60依26.74e 703.20依8.45 639.00依17.33c 687.20依14.56 727.80依9.89d
WBC (K/uL)     6.00依0.24   17.62依0.70a   13.04依0.82a,d 9.62依0.48b,d 4.60依0.15 8.40依0.40a 6.32依0.19a,d 5.06依0.16d
LYM (%)   68.40依1.95   45.98依1.58a   48.28依1.89a 57.70依0.44b,d 62.38依4.10 18.36依1.89a 44.04依1.45a,d 49.92依1.50c,d
MID (%)   16.06依0.93   38.00依3.48a   29.20依1.65a,f 23.30依1.25d 14.16依1.61 62.72依2.71a 27.92依0.80a,d 25.44依1.42b,d
Granulo (%)   15.54依1.82 1  6.04依2.30   22.52依0.62 19.00依1.63 24.30依2.82 18.80依2.40 28.04依1.56 24.64依2.85
Total 
proteins (g/dL) 5.72依0.23 14.38依0.78a 8.18依0.62c,d 6.64依0.43d 5.35依0.11 14.27依0.42a 10.70依0.35a,d 6.44依0.29d
Data were expressed as Mean依SEM; Hematological parameters (total red blood cell = RBC, white blood cells = WBC, lymphocytes = LYM, 
platelet = PLT, hematocrit = HCT, hemoglobin = HGB, mean corpuscular volume = MCV, mean corpuscular hemoglobin = MCH, mean 
corpuscular hemoglobin concentration = MCHC, red blood cell distribution width = RDW and MID cells = less frequently occurring and rate 
cells correlating to monocytes, eosinophils, basophils etc., aP<0.001; bP<0.01; cP<0.05  vs. Normal; dP<0.001; eP<0.01; fP<0.05 vs. tumor 
control. Data were analysed by One way ANOVA followed by Tukey Kramer Multiple comparison test.
 
Table 4




LPO SOD CAT GPx GST LPO SOD CAT GPx GST
Normal 7.16依0.45 0.48依0.02 35.08依1.42 16.80依0.44 0.19依0.01 5.26依0.19 0.42依0.02 32.30依1.16 16.60依0.83 0.18依0.01
Tumor control 32.80依1.12a 0.17依0.01a 18.20依1.45a 52.16依1.39a 0.45依0.02a 32.70依1.41a 0.15依0.02a 14.58依0.72a 47.50依1.84a 0.39依0.01a
MEIC 200 22.80依0.98a,c 0.25依0.02a,e 20.90依0.55a 31.48依1.56a,c 0.36依0.01a,d 19.17依0.71a,d 0.24依0.01a,e 22.00依1.30a,e 26.91依1.64a,d 0.24依0.01c,d
MEIC 400 13.02依0.89b,c 0.34依0.01a,c 26.02依1.41a,d 24.04依0.53b,c 0.28依0.01b,c 12.66依1.02a,d 0.37依0.02d 25.10依1.35b,d 23.87依0.86b,d 0.20依0.01d
n=5; Data were expressed as mean依SEM, aP<0.001; bP<0.01; cP<0.05 vs. Normal; dP<0.001 vs. Tumor control; Data were analyzed by Tukey-
Kramer multiple comparison test. LPO, 毺 moles of MDA/min/mg protein; SOD, units/min/mg protein; CAT, 毺 mole of H2O2 consumed/min/mg 
protein; GPx, 毺 moles of GSH oxidized/min/mg protein; GST, 毺 moles of CDNB conjugation formed/min/mg protein.
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4. Discussion
  The effect of methanol extract of I. cassioides has been 
studied on several human cancer cell lines and normal 
cell lines as well as in murine tumor models. Our results 
show that the extract has potent cytotoxic and anticancer 
potential in vitro and in vivo. The extract treatment showed 
concentration dependent inhibition of cell growth of human 
cancer cell lines studies. The IC50 value varied depending 
upon the cell line. The effect was more pronounced against 
HEpG2 cell lines. This demonstrated the difference in 
sensitivity of cancer cell lines to phytochemicals containing 
in I. cassioides. This may also be due to different molecular 
characteristics of these cells. Further, the differential 
cytotoxicity of the extract against different human cancer 
cell lines shows that its use against different types of cancers 
might present positive results. At the same time, the IC50 
value for normal cell lines were found to be very high which 
indicated that the selectivity of the plant extract towards the 
cancer cells.
  A reliable criterion for assessing the potential of any 
anticancer agent is the prolongation of the life span of the 
tumor bearing animals. An increase in life span of ascites 
bearing animals by 25% is considered as an indicative 
of significant drug activity. Our results show an increase 
in life span accompanied by a reduction in WBC count in 
MEIC treated mice. The plant extract also inhibited the 
accumulation of ascitic fluid in the peritoneal cavity of the 
tumor bearing animals. This suggests that the cytotoxic 
activity of MEIC on the transplantable tumor cells might be 
due to mechanisms including cytolytic effect. Cytological 
studies of leishman stained tumor cell streaks have revealed 
a decrease in the number of mitotic cells following MEIC 
treatment when compared with that of control. Degenerative 
changes in treatment group have been observed in the 
form of membrane blebbing, vacuolated cytoplasm and a 
reductive in the staining intensity.
  The most common problems encountered in cancer 
chemotherapy are myelosuppression and anemia. Similar 
results were observed in the present study in animals of 
the EAC and DLA tumor control group. This is mainly due 
to reduction in RBC or hemoglobin production and this 
may occur either due to the iron deficiency or to hemolytic 
or other myelopathic conditions [14]. Treatment with MEIC 
brought back the hemoglobin content, RBC and WBC counts 
closer to normal level. This indicates that the extract have a 
protective effect on the hemopoietic system.
  Cell proliferation, a characteristic feature of cancer, is 
inversely proportional to lipid peroxidation and cancer itself 
imparts an oxidative stress on the host. This is illustrated 
by the rapid elevation of lipid peroxidation and impaired 
antioxidant status of mice with various types of tumors. 
Several studies have demonstrated that tumor bearing 
animals can experience a systemic change of antioxidant 
enzymes in organs distant from the tumor. The tumor cells 
produce substantial amount of hydrogen peroxide, which 
may be released into circulation and then transported to the 
liver for detoxification [15]. Further, growing tumors sequester 
essential antioxidants from the host tissues and meet their 
demand [16]. So, the observed elevated levels of LPO in the 
liver of EAC and DLA tumor bearing animals may be due to 
the excessive generation of hydrogen peroxide by peritoneal 
cells that has been transferred to liver for detoxification 
along with the sequestration of antioxidant by tumor cells [17]. 
Treatment with MEIC significantly decreases the levels of 
LPO and shows its protective role on the liver by decreasing 
the tumor burden. GST and GPx are metabolic enzymes 
involved in the detoxification of free radicals, carcinogens 
and peroxides by conjugating these toxic substances with 
GSH, ultimately protecting the cells and organs from the 
oxidative stress. Treatment with MEIC decrease the tumor 
burden, hence decrease the oxidative stress, which in turns 
results in the restored levels of these enzymes. 
  SOD and catalase are considered as primary antioxidant 
enzymes, since they are involved in the direct elimination 
of the reactive oxygen species [18]. Catalase depression in 
liver is a well established phenomenon with tumor burden 
and decreased SOD activities were also seen in many organs 
of tumor bearing animals. Our results are in agreement 
with the above findings and treatment with MEIC effectively 
reduces the oxidative stress in tumor bearing animals and 
restored the activities of enzymic antioxidants. 
  Plant derived extracts containing antioxidant principles 
showed cytotoxicity towards tumor cells and antitumor 
activity in experimental animals. Antitumor activity of 
these antioxidants is either through induction of apoptosis 
or by inhibition of angiogenesis. The involvement of free 
radicals in tumors is well documented. The lowering of lipid 
peroxidation, GST, GPx and increase in levels of SOD and 
catalase in MEIC treated group indicates its potential as an 
inhibitor of tumor induced intracellular oxidative stress.
  MEIC treatment decreased the volume of solid tumor and 
it may concluded that the extract, by a direct cytotoxic 
effect arresting the tumor cell growth. The results were also 
supported by the cytotoxic effects of the extract towards EAC 
Table 5 




15th day 20th day 25th day 30th day 15th day 20th day 25th day 30th day
Tumor control 1.53依0.07 1.81依0.28 2.23依0.18 3.93依0.35 1.72依0.09 1.85依0.09 2.25依0.09 3.00依0.19
MEIC 200 1.14依0.1a 1.60依0.18 2.04依0.18 3.15依0.34 1.37依0.13b 1.54依0.12b 1.93依0.13b 2.38依0.18b
MEIC 400 1.06依0.05a 1.10依0.16b 1.73依0.28 2.33依0.24a 1.30依0.05a 1.42依0.03a 1.68依0.07a 1.90依0.05a
n=6, Data were expressed as Mean依SEM aP<0.01; bP<0.05 vs Tumor Control, Data were analyzed by using one way ANOVA followed by 
Dunnett’s test.
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and DLA cell lines.
  The exact mechanism by which I. cassioides mediates its 
antitumor activity is unknown. However, some compounds 
present in the extract such as flavonoids, terpenoids 
and saponins [19, 20] could explain these results. These 
compounds have been mentioned as antioxidants and 
consequently involved in antitumor activities. Flavonoids 
have been found to possess antimutagenic and antimalignant 
effect. Moreover, they have a chemo preventive role in 
cancer through their effects on signal transduction in cell 
proliferation and inhibition of neovascularization [21-25]. 
Saponins have been found beneficial targeted on inhibition 
of tumor angiogenesis by suppressing its inducer in the 
epithelial cells of blood vessels and then on adhering, 
invasion and metastasis of tumor cells. They also exhibit 
the antitumor effect by cell cycle arrest and apoptosis [20]. 
We propose that the additive and synergistic antioxidant 
activity of phytochemicals such as flavonoids, polyphenols 
and terpenoids present in I. cassioides are responsible for 
its potent antitumor activity which can be inferred from the 
increased life span of tumor bearing mice and the inhibition 
of solid tumor growth.
  In conclusion, the MEIC treatment was effective in 
inhibiting the tumor growth in vitro and in vivo models. 
Further investigations are in progress in our laboratory to 
identify the active principles and the mechanisms involved 
in this antitumor activity.
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